OTTAWA, May 23, 2018 /CNW/ - Protecting the safety and security of Canada's blood supplyand blood products is a priority for Health Canada. Many Canadians rely on life-saving products made from human plasma, including immune globulins, to treat various health conditions.
In 2017, Health Canada established an Expert Panel to provide
The Panel consisted of two members supported by two special advisors who collectively possess the relevant domestic and international expertise and experience. From August 2017 to March 2018, the Panel engaged a wide range of experts and stakeholders, attended international conferences, undertook a literature review, and solicited input from provinces, territories, federal officials and the National Advisory Committee on Blood and Blood Products.
Health Canada will take the time necessary to review the Expert Panel's findings and will work with its partners—the provinces and territories, Canadian Blood Services (CBS) and Héma-Québec—to determine the best path forward to ensure Canadians continue to have access to safe blood and blood products when they need them.
SOURCE Health Canada
Subscribe to our Free Newsletters!
Collagen plays a crucial role in glowing skin, strong nails and shiny hair. You can boost collagen ...
CRISPR technology is a simple but potent tool for editing any part of the genome (complete set of ...
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...View All